FDA Panel Reiterates the Cancer Risks of Talc
Go back to FDA Panel Reiterates the Cancer Risks of Talc| Johnson & Johnson (NYSE: JNJ) | Delayed: 260.25 +5.47 (2.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $254.78 | 52 Week High | $126.07 | |||
| Open | $256.21 | 52 Week Low | $94.28 | |||
| Day High | $260.68 | P/E | 54.11 | |||
| Day Low | $255.73 | EPS | $4.81 | |||
| Volume | 2,336,655 | |||||



